Trial intelligence / Profile preview

Benvinomod cream in atopic dermatitis phase II trial

CTR20170625Phase 2Completed

Sponsor
Guangdong Zhonghao Pharmaceutical
Start
Sep 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of tapinarof in atopic dermatitis (AD), sponsored by Guangdong Zhonghao Pharmaceutical. Started Sep 2017; status: completed.

02

Drugs

tapinarof
03

Conditions

atopic dermatitis (AD)

Beyond the preview

Go deeper on CTR20170625.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20170625.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call